Shock management in acute myocardial infarction

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), affecting approximately 10% of patients.
• CS is characterized by critical hypoperfusion due to diminished cardiac contractility, leading to end-organ damage.
• Despite advances, CS carries a high mortality rate, underscoring the need for improved management strategies.

Purpose of the Study:

• To outline current and novel therapeutic strategies for cardiogenic shock (CS) in acute myocardial infarction (AMI).
• To provide an interventional cardiologist's perspective on managing CS.
• To highlight areas requiring further research to improve patient outcomes.

Main Methods:

• Review of existing literature and emerging therapeutic approaches for CS.
• Focus on interventional cardiology techniques and their role in CS management.
• Discussion of multi-system support and resource allocation in CS patients.

Main Results:

• Early revascularization has reduced CS incidence but has not significantly lowered its high mortality rate (approaching 50%).
• CS involves systemic circulatory compromise, necessitating a comprehensive treatment approach.
• Optimal management requires careful decisions regarding revascularization, pharmacotherapy, mechanical support, and intensive care.

Conclusions:

• Mortality from cardiogenic shock (CS) remains unacceptably high.
• There is a significant lack of high-quality evidence for many CS treatment modalities.
• Further well-designed studies are crucial to address unresolved questions and improve CS survival.